Agios Pharmaceuticals Inc (AGIO):企業の財務・戦略的SWOT分析

◆英語タイトル:Agios Pharmaceuticals Inc (AGIO) - Financial and Strategic SWOT Analysis Review
◆レポート形式:英語 / PDF
Single User(1名様閲覧用)USD300 ⇒換算¥43,800見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD600 ⇒換算¥87,600見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD900 ⇒換算¥131,400見積依頼/購入/質問フォーム


Agios Pharmaceuticals Inc (Agios) is a biopharmaceutical company that focuses on the discovery and development of investigational medicines for the treatment of cancer and rare genetic metabolic disorders. The company’s products include IDHIFA, an oral targeted inhibitor of the mutated IDH2 enzyme used for the treatment of patients with R/R acute myeloid leukemia (AML); and TIBSOVO (ivosidenib), a prescription medicine used to treat adults with AML. Its pipeline products include AG-881, a pan-IDH mutant inhibitor intended for the treatment of hematologic malignancies and solid tumors; AG-270, an inhibitor of methionine adenosyltransferase 2a; and Mitapivat, a potent activator intended for the treatment of patients with pyruvate kinase deficiency. Agios is headquartered in Cambridge, Massachusetts, the US.

Agios Pharmaceuticals Inc Key Recent Developments

Feb 25,2019: Agios Reports Updated Data from Phase 1 Study of Ivosidenib in Combination with Azacitidine Demonstrating Deep and Durable Responses in Newly Diagnosed IDH1 Mutant Acute Myeloid Leukemia (AML) Patients
Feb 14,2019: Agios reports fourth quarter and full year 2018 financial results
Nov 01,2018: Agios reports third quarter 2018 financial results
Sep 05,2018: 2018 Veeva R&D summit to showcase advances for speeding product development
Sep 04,2018: Agios Announces Chief Executive Officer Succession Plan

This comprehensive SWOT profile of Agios Pharmaceuticals Inc provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Agios Pharmaceuticals Inc including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.


Table of Contents

Section 1 – About the Company

Agios Pharmaceuticals Inc – Key Information
Agios Pharmaceuticals Inc – Overview
Agios Pharmaceuticals Inc – Key Employees
Agios Pharmaceuticals Inc – Key Employee Biographies
Agios Pharmaceuticals Inc – Key Operational Heads
Agios Pharmaceuticals Inc – Major Products and Services
Agios Pharmaceuticals Inc – History
Agios Pharmaceuticals Inc – Company Statement
Agios Pharmaceuticals Inc – Locations And Subsidiaries
Agios Pharmaceuticals Inc – Key Manufacturing facilities
Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis

Agios Pharmaceuticals Inc – Business Description
Agios Pharmaceuticals Inc – Corporate Strategy
Agios Pharmaceuticals Inc – SWOT Analysis
SWOT Analysis – Overview
Agios Pharmaceuticals Inc – Strengths
Agios Pharmaceuticals Inc – Weaknesses
Agios Pharmaceuticals Inc – Opportunities
Agios Pharmaceuticals Inc – Threats
Agios Pharmaceuticals Inc – Key Competitors

Section 3 – Company Financial Performance Charts

Agios Pharmaceuticals Inc – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts

Section 4 – Appendix

Ratio Definitions
About GlobalData
Contact Us

Note*: Some sections may be missing if data is unavailable for the company

List of Tables

Agios Pharmaceuticals Inc, Key Information
Agios Pharmaceuticals Inc, Key Ratios
Agios Pharmaceuticals Inc, Share Data
Agios Pharmaceuticals Inc, Major Products and Services
Agios Pharmaceuticals Inc, History
Agios Pharmaceuticals Inc, Key Employees
Agios Pharmaceuticals Inc, Key Employee Biographies
Agios Pharmaceuticals Inc, Key Operational Heads
Agios Pharmaceuticals Inc, Other Locations
Agios Pharmaceuticals Inc, Subsidiaries
Agios Pharmaceuticals Inc, Key Manufacturing facilities
Agios Pharmaceuticals Inc, Key Competitors
Agios Pharmaceuticals Inc, SWOT Analysis
Agios Pharmaceuticals Inc, Ratios based on current share price
Agios Pharmaceuticals Inc, Annual Ratios
Agios Pharmaceuticals Inc, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures

Agios Pharmaceuticals Inc, Performance Chart
Agios Pharmaceuticals Inc, Ratio Charts


★リサーチレポート[ Agios Pharmaceuticals Inc (AGIO):企業の財務・戦略的SWOT分析(Agios Pharmaceuticals Inc (AGIO) - Financial and Strategic SWOT Analysis Review)]についてメールでお問い合わせはこちらでお願いします。